Hypertension and cerebral blood flow: Implications for the development of vascular cognitive impairment in the elderly

Stroke

Volumn 38, Issue 6, 2007, Pages 1715-1717

  Cohen, Ronald A ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

Cerebral blood flow; Hypertension; Vascular cognitive impairment

Indexed keywords

AMYLOID BETA PROTEIN; TAU PROTEIN;

ALZHEIMER DISEASE; BRAIN BLOOD FLOW; BRAIN INFARCTION; CEREBROVASCULAR DISEASE; CHOLINERGIC SYSTEM; COGNITION; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; EDITORIAL; HUMAN; HYPERTENSION; MEMORY DISORDER; MICROVASCULAR ISCHEMIA; MULTIINFARCT DEMENTIA; NEUROIMAGING; NEUROPATHOLOGY; NEUROPSYCHOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RISK FACTOR; STROKE;

AGED; BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; COGNITION DISORDERS; DEMENTIA, VASCULAR; HUMANS; HYPERTENSION;

EID: 34249825212     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.107.487165     Document Type: Editorial

References (26)

1. Selkoe DJ. The deposition of amyloid proteins in the aging mammalian brain: implications for Alzheimer's disease. Ann Med. 1989;21:73-76.
2. Shukla C, Bridges LR. Tau, beta-amyloid and beta-amyloid precursor protein distribution in the entorhinal-hippocampal alvear and perforant pathways in the Alzheimer's brain. Neurosci Lett. 2001;303:193-197.
3. Cacabelos R, Fernandez-Novoa L, Lombardi V, Corzo L, Pichel V, Kubota Y. Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications. Neurol Res. 2003;25:567-580.
4. Kalaria RN. Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease. Ann N Y Acad Sci. 1997;826:263-271.
5. Farkas E, De Vos RA, Jansen Steur EN, Luiten PG. Are Alzheimer's disease, hypertension, and cerebrocapillary damage related? Neurobiol Aging. 2000;21:235-243.
6. Kalback W, Esh C, Castano EM, Rahman A, Kokjohn T, Luehrs DC, Sue L, Cisneros R, Gerber F, Richardson C, Bohrmann B, Walker DG, Beach TG, Roher AE. Atherosclerosis, vascular amyloidosis and brain hypoperfusion in the pathogenesis of sporadic Alzheimer's disease. Neurol Res. 2004;26:525-539.
7. de la Torre JC, Stefano GB. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide. Brain Res Brain Res Rev. 2000;34:119-136.
8. Roman GC, Kalaria RN. Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia. Neurobiol Aging. 2006;27:1769-1785.
9. Andin U, Passant U, Gustafson L, Englund E. Alzheimer's disease (AD) with and without white matter pathology-clinical identification of concurrent cardiovascular disorders. Arch Gerontol Geriatr. 2007;44:277-286.
10. Meyer JS, Rauch GM, Rauch RA, Haque A, Crawford K. Cardiovascular and other risk factors for Alzheimer's disease and vascular dementia. Ann N Y Acad Sci. 2000;903:411-423.
11. Andin U, Passant U, Gustafson L, Englund E. Alzheimer's disease (AD) with and without white matter pathology-clinical identification of concurrent cardiovascular disorders. Arch Gerontol Geriatr. 2007;44:277-286.
12. Andresen J, Shari NI, Bryan RM Jr. Endothelial influences on cerebrovascular tone. Applied Physiology. 2006;100:318-327.
13. Skoog I, Gustafson D. Hypertension, hypertension-clustering factors and Alzheimer's disease. Neurol Res. 2003;25:675-680.
14. Skoog I, Kalaria RN, Breteler MM. Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. 1999;13 (Suppl 3):S106-114.
15. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, and the NINDS-AIREN Workgroup. Vascular dementia: diagnostic criteria for research studies. Report of the ninds-airen international workshop. Neurology. 1993;43:250-260.
16. Paul R, Cohen R, Ott B, Salloway S. Vascular Dementia: Cerebrovascular Mechanisms and Clinical Management (current clinical neurology) Totowa, NJ: Humana Press; 2004.
17. Caplan LR. Caplan's Stroke: A Clinical Approach. New York: Butterworth-Heinemann; 2000.
18. Heilman K, Valenstein, E. Clinical Neuropsychology. New York: Oxford University Press; 2001.
19. Jefferson AL, Poppas A, Paul RH, Cohen RA. Systemic hypoperfusion is associated with executive dysfunction in geriatric cardiac patients. Neurobiol Aging. 2007;28:477-483.
20. Haley AP, Forman DE, Poppas A, Hoth KF, Gunstad J, Jefferson AL, Paul RH, Ler AS, Sweet LH, Cohen RA. Carotid artery intima-media thickness and cognition in cardiovascular disease. Int J Cardiol. 2006.
21. Hoth KF, Tate DF, Poppas A, Forman DE, Gunstad J, Moser DJ, Paul RH, Jefferson AL, Haley AP, Cohen RA. Endothelial function and white matter hyperintensities in older adults with cardiovascular disease. Stroke. 2007;38:308-312.
22. Paul RH, Gunstad J, Poppas A, Tate DF, Foreman D, Brickman AM, Jefferson AL, Hoth K, Cohen RA. Neuroimaging and cardiac correlates of cognitive function among patients with cardiac disease. Cerebrovasc Dis. 2005;20:129-133.
23. Beason-Held LL, Moghekar A, Zonderman AB, Kraut MA, Resnick SM. Longitudinal changes in cerebral blood flow in the older hypertensive brain. Stroke. 2007;38:1766-1773.
24. Jeerakathil T, Wolf PA, Beiser A, Massaro J, Seshadri S, D'Agostino RB, DeCarli C. Stroke risk profile predicts white matter hyperintensity volume: The Framingham study. Stroke. 2004;35:1857-1861.
25. Bornstein N, Silvestrelli G, Caso V, Parnetti L. Arterial hypertension and stroke prevention: an update. Clin Exp Hypertens. 2006;28:317-326.
26. Junga K, Merlo J, Gullberg B, Bog-Hansen E, Rastam L, Lindblad U. Residual risk for acute stroke in patients with type 2 diabetes and hypertension in primary care: Skaraborg hypertension and diabetes project. Diabetes Obes Metab. 2006;8:492-500.